Abstract:The transcription factor p53 is under negative regulation by the ubiquitin ligase MDM2 and its close homologue MDM4. In the bound complex between MDM2 and p53, the transactivation domain of p53 adopts an amphipathic helical conformation which optimizes the spatial organization of three key hydrophobic residues (Phe19, Trp23, Leu26) for maximum interactions. The interaction with MDM2 is known to be abrogated by phosphorylation of Ser/Thr residues in the MDM2 N-terminal domain and in the p53 transactivation domain. In the latter, phosphorylation of Thr18 has been attributed to destabilize a key hbond between Thr18 and Asp21. This interaction has been thought to be critical for the formation of the helical conformation of the p53 transactivation domain. Molecular dynamics simulations of the p53 transactivation domain suggest that phosphorylation of either Thr18 or Ser20 does not disrupt its helical structure but does result in reduced affinities for MDM2. While interactions between the Thr18 and Asp21 are indeed broken due to charge-charge repulsions, the peptide has enough inherent flexibility to form alternate patterns of hbonds, resulting in the maintenance of helicity. Electrostatics of MDM2 reveal local anionic patches in the region where Thr18 docks. These suggest that repulsions will arise because the MDM2 surface will force the p53 to bind in a manner that will place the negatively charged phosphorylated Thr18 near this anionic region. A similar, albeit somewhat attenuated pattern of electrostatic modulations, is seen for a model of MDM4 that has been built. Mutants of MDM2 and MDM4 have been designed to attenuate this anionicity and have been computationally demonstrated to enhance the binding of the phosphorylated peptides.

Interplay Between MDM2, MDMX, Pirh2 and COP1: the Negative Regulators of P53

Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Complex Structures of Human MDM2 with Interacting Proteins Reveal the Regulation Mechanism of P53

Research progress of regulation mechanism of MDMX and CK1αin p53 tumor suppressor protein

Secondary Interaction Between MDMX and P53 Core Domain Inhibits P53 DNA Binding.

Small Molecule Inhibitors of the P53-Mdm2

The ubiquitin ligase COP1 is a critical negative regulator of p53

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

P300/mdm2 Complexes Participate in MDM2-mediated P53 Degradation.

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

Mdm2 is A Negative Regulator of P21(Waf1/Cip1), Independent of P53

Protein Phosphatase 1 Inhibits P53 Signaling by Dephosphorylating and Stabilizing Mdmx

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

The p53 mRNA-Mdm2 interaction

The Regulation of MDM2 Oncogene and Its Impact on Human Cancers

RB Regulates the Stability and the Apoptotic Function of P53 Via MDM2

Stabilization of E2F1 Protein by MDM2 Through the E2F1 Ubiquitination Pathway

XPC promotes MDM2-mediated degradation of the p53 tumor suppressor.

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels Of Mdm2-Mediated P53 Ubiquitination